Publication Name	World Journal of Clinical Cases
Manuscript ID	86640
Country	Japan

Received	2023-06-29 01:21
Peer-Review Started	2023-06-29 01:23
To Make the First Decision
Return for Revision	2023-09-28 09:45
Revised	2023-10-10 14:22
Second Decision	2023-10-17 03:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-10-23 01:49
Articles in Press	2023-10-23 01:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-10-30 00:58
Publish the Manuscript Online	2023-11-06 09:10

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Sunitinib-induced hyperammonemic encephalopathy in metastatic gastrointestinal stromal tumors: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Takaoki Hayakawa, Shinsuke Funakoshi, Yasuo Hamamoto, Kenro Hirata and Takanori Kanai
Funding Agency and Grant Number
Corresponding Author	Yasuo Hamamoto, MD, PhD, Assistant Professor, Doctor, Keio Cancer Center, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku 160-8582, Tokyo, Japan. yashmmt1971@gmail.com
Key Words	Tyrosine protein kinase inhibitors; Sunitinib malate; Hyperammonemic encephalopathy; Gastrointestinal stromal tumors; Case report
Core Tip	This case is distinctive because the patient was diagnosed with a rare hyperammonemic encephalopathy caused by sunitinib, which was administered as treatment for gastrointestinal stromal tumors. We emphasize the need for systemic evaluation and prompt action for patients receiving tyrosine kinase inhibitors who present with adverse effects.
Publish Date	2023-11-06 09:10
Citation	Hayakawa T, Funakoshi S, Hamamoto Y, Hirata K, Kanai T. Sunitinib-induced hyperammonemic encephalopathy in metastatic gastrointestinal stromal tumors: A case report. World J Clin Cases 2023; 11(31): 7629-7634
URL	https://www.wjgnet.com/2307-8960/full/v11/i31/7629.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i31.7629

Full Article (PDF)	WJCC-11-7629-with-cover.pdf
Full Article (Word)	WJCC-11-7629.docx
CARE Checklist–2016	86640-CARE Checklist (2016).pdf
Manuscript File	86640_Auto_Edited-LJH-JLW.docx
Answering Reviewers	86640-Answering reviewers.pdf
Audio Core Tip	86640-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	86640-Conflict-of-interest statement.pdf
Copyright License Agreement	86640-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	86640-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	86640-Language certificate.pdf
Peer-review Report	86640-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	86640-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	86640-Bing-Liu JH-2.png
Scientific Misconduct Check	86640-CrossCheck.png
Scientific Editor Work List	86640-Scientific editor work list.pdf